Adlai Nortye Ltd. Files 20-F/A Amendment

Ticker: ANL · Form: 20-F/A · Filed: May 12, 2025 · CIK: 1944552

Sentiment: neutral

Topics: annual-report, amendment, sec-filing

TL;DR

Adlai Nortye filed its 2024 annual report amendment (20-F/A) on May 12, 2025.

AI Summary

Adlai Nortye Ltd. filed an amendment (20-F/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on May 12, 2025, is an amendment to their existing registration statement. The company is incorporated in Delaware and operates in the pharmaceutical preparations sector.

Why It Matters

This filing provides updated information for the fiscal year 2024, which is crucial for investors to assess the company's financial health and operational status.

Risk Assessment

Risk Level: low — This filing is an amendment to an annual report and does not appear to contain new material adverse information.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 20-F/A filing?

This filing is an amendment to the annual report (Form 20-F) for the fiscal year ended December 31, 2024, as indicated by the form type '20-F/A'.

What is Adlai Nortye Ltd.'s fiscal year end?

Adlai Nortye Ltd.'s fiscal year ends on December 31, as stated in the filing details.

When was this amendment filed with the SEC?

The amendment was filed on May 12, 2025.

What industry does Adlai Nortye Ltd. operate in?

Adlai Nortye Ltd. operates in the Pharmaceutical Preparations industry, with SIC code 2834.

What is the SEC file number associated with Adlai Nortye Ltd.?

The SEC file number for Adlai Nortye Ltd. is 001-41773.

Filing Details

This Form 20-F/A (Form 20-F/A) was filed with the SEC on May 12, 2025 regarding Adlai Nortye Ltd. (ANL).

View full filing on EDGAR

View Full Filing

View this 20-F/A filing on SEC EDGAR

View on Read The Filing